These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11432419)

  • 41. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
    J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fifteen years of successful spread of Salmonella enterica serovar Mbandaka clone ST413 in Poland and its public health consequences.
    Hoszowski A; Zając M; Lalak A; Przemyk P; Wasyl D
    Ann Agric Environ Med; 2016 Jun; 23(2):237-41. PubMed ID: 27294625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The epidemiology of bacterial resistance to quinolones.
    Acar JF; O'Brien TF; Goldstein FW; Jones RN
    Drugs; 1993; 45 Suppl 3():24-8. PubMed ID: 7689447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial resistance of Salmonella serovars isolated from beef at retail markets in the north Vietnam.
    Thai TH; Hirai T; Lan NT; Shimada A; Ngoc PT; Yamaguchi R
    J Vet Med Sci; 2012 Sep; 74(9):1163-9. PubMed ID: 22673721
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spread of resistance from food animals to man--the UK experience.
    Threlfall EJ; Ward LR; Frost JA; Willshaw GA
    Acta Vet Scand Suppl; 2000; 93():63-8; discussion 68-74. PubMed ID: 10822859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topoisomerase IV mutations in quinolone-resistant salmonellae selected in vitro.
    Hansen H; Heisig P
    Microb Drug Resist; 2003; 9(1):25-32. PubMed ID: 12705680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Growing incidence of nalidixic acid resistance and sensitivity to quinolones in Salmonella typhimurium strains isolated from man or animal].
    Heurtin-Le Corre C; Donnio PY; Bonnier M; Travert MF; Lacourt A; Avril JL
    Pathol Biol (Paris); 1998 Oct; 46(8):587-90. PubMed ID: 9871929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quinolone resistance in the food chain.
    Fàbrega A; Sánchez-Céspedes J; Soto S; Vila J
    Int J Antimicrob Agents; 2008 Apr; 31(4):307-15. PubMed ID: 18308515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Two cases of typhoid fever with reduced susceptibility to fluoroquinolones].
    Adachi T; Masuda G; Imamura A; Ajisawa A; Negishi M; Takayama N; Takinaga K; Takano S
    Kansenshogaku Zasshi; 2001 Jan; 75(1):48-52. PubMed ID: 11218386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is salmonellosis still a serious problem in veterinary practice?
    Wray C
    Vet Rec; 1985 May; 116(18):485-9. PubMed ID: 4013036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence, characterization and antibiotic resistance of Salmonella isolates in large corvid species of europe and north America between 2010 and 2013.
    Janecko N; Čížek A; Halová D; Karpíšková R; Myšková P; Literák I
    Zoonoses Public Health; 2015 Jun; 62(4):292-300. PubMed ID: 25103698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishment of a national surveillance program for antimicrobial resistance in Salmonella.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Feb; 45(5):110-1. PubMed ID: 8592493
    [No Abstract]   [Full Text] [Related]  

  • 53. [Salmonella enteritis in dogs, not relevant?].
    van Duijkeren E; Houwers D
    Tijdschr Diergeneeskd; 2002 Dec; 127(23):716-7. PubMed ID: 12491970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-level resistance to fluoroquinolones among Salmonella and Shigella.
    Willke A
    Clin Microbiol Infect; 2000 Dec; 6(12):687. PubMed ID: 11284932
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of several fluoroquinolones and beta-lactams in terms of their capability to restrict the selection of fluoroquinolone-resistant Salmonella: in vitro models.
    Cebríán L; Rodríguez JC; Escribiano I; Royo SG
    APMIS; 2007 Dec; 115(12):1376-82. PubMed ID: 18184408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quinolone antibiotics in the treatment of Salmonella infections.
    Asperilla MO; Smego RA; Scott LK
    Rev Infect Dis; 1990; 12(5):873-89. PubMed ID: 2237130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristics of bacterial pathogens associated with acute diarrhea in children under 5 years of age: a hospital-based cross-sectional study.
    Tian L; Zhu X; Chen Z; Liu W; Li S; Yu W; Zhang W; Xiang X; Sun Z
    BMC Infect Dis; 2016 Jun; 16():253. PubMed ID: 27267601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
    Crump JA; Barrett TJ; Nelson JT; Angulo FJ
    Clin Infect Dis; 2003 Jul; 37(1):75-81. PubMed ID: 12830411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Susceptibility to quinolones of Salmonella isolated from men and animals].
    Avril JL; Couete I; Travert MF; Autuly F; Plessis P
    Pathol Biol (Paris); 1995 Apr; 43(4):270-3. PubMed ID: 7567113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enrofloxacin treatment of gram-negative infections.
    Rutgers HC; Stepien RL; Elwood CM; Simpson KW; Batt RM
    Vet Rec; 1994 Oct; 135(15):357-9. PubMed ID: 7846824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.